Literature DB >> 12058884

The acute effects of glycemic control on axonal excitability in human diabetic nerves.

Satoshi Kuwabara1, Kazue Ogawara, Takamichi Harrori, Yoshifumi Suzuki, Naotake Hashimoto.   

Abstract

OBJECTIVE: To investigate whether glycemic control is associated with reversible changes in axonal excitability in human diabetic nerves. It is known that voluntary contraction or compression ischemia alters nerve Na+/K+ pump activity, and axonal excitability changes due to the pump activity can be estimated by threshold tracking.
METHODS: Threshold, the current required to produce a compound muscle action potential 50% of maximum, was determined from the stimulus-response curve, and threshold changes produced by maximal voluntary contraction or ischemia were measured before and after insulin treatment in 10 diabetic patients.
RESULTS: Within 3 weeks of the start of treatment, the threshold changes became greater following voluntary contractions (+13+/-4% versus +23+/-5%; mean+/-SEM; p=0.04) and during ischemia (-5+/-2% versus -11+/-2%; p=0.04).
CONCLUSIONS: The extent of threshold fluctuation depends on multiple metabolic factors associated with diabetes such as decreased Na+/K+ ATPase activity, increased anaerobic glycolysis, and tissue acidosis, and nerve excitability can respond quickly to glycemic control in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12058884     DOI: 10.2169/internalmedicine.41.360

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  8 in total

1.  Axonal Excitability Does Not Differ between Painful and Painless Diabetic or Chemotherapy-Induced Distal Symmetrical Polyneuropathy in a Multicenter Observational Study.

Authors:  Andreas C Themistocleous; Alexander G Kristensen; Roma Sola; Sandra S Gylfadottir; Kristine Bennedsgaard; Mustapha Itani; Thomas Krøigård; Lise Ventzel; Søren H Sindrup; Troels S Jensen; Hugh Bostock; Jordi Serra; Nanna B Finnerup; Hatice Tankisi; David L H Bennett
Journal:  Ann Neurol       Date:  2022-03-07       Impact factor: 11.274

2.  Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes.

Authors:  Jia-Ying Sung; Susanna B Park; Ya-Ting Liu; Natalie Kwai; Ria Arnold; Arun V Krishnan; Cindy S-Y Lin
Journal:  Diabetes       Date:  2012-04-20       Impact factor: 9.461

3.  Response to comment on Malik. Which test for diagnosing early human diabetic neuropathy? Diabetes 2014;63:2206-2208.

Authors:  Ioannis N Petropoulos; Mitra Tavakoli; Andrew Marshall; Rayaz A Malik
Journal:  Diabetes       Date:  2015-02       Impact factor: 9.461

4.  Negative impact of gestational diabetes mellitus on progress of pelvic floor muscle electromyography activity: Cohort study.

Authors:  Caroline B Prudencio; Marilza V C Rudge; Fabiane A Pinheiro; Carlos I Sartorão Filho; Sthefanie K Nunes; Cristiane R Pedroni; Baerbel Junginger; Angélica M P Barbosa
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

5.  Metabolic syndrome and anthropometric indices in CTS hands: an electrophysiological study.

Authors:  Mahir Yusifov; Sezin Alpaydin Baslo; Betül Tekin; Mucahid Erdogan; Oya Ozturk; Dilek Atakli
Journal:  Neurol Sci       Date:  2021-07-10       Impact factor: 3.307

6.  Why are sensory axons more vulnerable for ischemia than motor axons?

Authors:  Jeannette Hofmeijer; Hessel Franssen; Leonard J van Schelven; Michel J A M van Putten
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

7.  Peripheral nerve axonal excitability studies: expanding the neurophysiologist's armamentarium.

Authors:  William Huynh; Matthew C Kiernan
Journal:  Cerebellum Ataxias       Date:  2015-03-03

8.  Uncovering sensory axonal dysfunction in asymptomatic type 2 diabetic neuropathy.

Authors:  Jia-Ying Sung; Jowy Tani; Tsui-San Chang; Cindy Shin-Yi Lin
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.